BBGBloomberg·2hHealth
Solemnscore-0.75
Cancer Drug Developer Erasca Sinks by Record 55% After Patient Death
Solemn (original framing only)
Cancer Drug Developer Erasca Sinks by Record 55% After Patient Death
“Catastrophic language ('sinks,' 'record 55%') combined with patient death creates alarm and fear without context about trial protocols or causation.”